Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
HONG KONG, June 12, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab (AK111), the company's internally-developed anti-IL-17 monoclonal antibody, for...
KT&G: "World's Largest Asset Manager BlackRock Increases stake from 5.01% to 6.15%"
- Foreign ownership rises to 51% based on strong overseas performance and enhanced shareholder returns - CEO Bang Kyung-man and senior management actively communicate with global investors through Overseas Non-Deal Roadshows (NDRs) SEOUL, South...
Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease
CAMBRIDGE, Mass. and TAIPEI, June 11, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced...
ToolGen Opens Advanced Field Testing Facility in Osong, Completing 'Bench-to-Field' Commercialization Platform for Global SAF and Industrial Crop Markets
Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization. Enables comprehensive field evaluation of a diversified crop portfolio, including drought tolerance,...
San José Homeowners Can Now Earn More Than $500 a Year by Enrolling Their FranklinWH Battery to the Grid
FranklinWH joins San Jose Clean Energy's Peak Rewards for Smart Homes program, offering battery owners upfront incentives and ongoing bill credits for helping stabilize the local grid during peak demand. SAN JOSE, Calif., June 10, 2026 /PRNewswire/...
CIBF 2026 Anchors Global Value Chains to Power Next-Gen Energy Storage
TIANJIN, China, June 10, 2026 /PRNewswire/ -- The 18th China International Battery Fair (CIBF 2026) concluded its three-day run at the Shenzhen World Exhibition & Convention Center. As the leading global gathering for the battery industry in the...
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, today announced a...
Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel
SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
SHANGHAI, June 8, 2026 /PRNewswire/ -- OriCell Therapeutics Holdings Limited ( The "Company" or "Oricell") , announced that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has received clearance from China's National Medical...
Hong Kong Web3 Festival: The Agent Economy and RWA Reshaping Global Finance Beyond the Event
HONG KONG, June 5, 2026 /PRNewswire/ -- Jointly hosted by Wanxiang Blockchain Labs and HashKey Group and organised by W3ME, the 4th Hong Kong Web3 Festival continues to resonate globally well after its conclusion. Drawing tens of thousands of...